Analysis of the Resistance and Sensitivity Mechanisms to Teclistamab by Focusing on Single Immune Cell Examination
Clinical trial NCT05945524 · RECRUITING
Trial details
- NCT number
- NCT05945524
- Sponsor
- University Hospital, Toulouse
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-28
- Primary completion
- 2026-03-31
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.